Cargando…
Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus
N-(4-hydroxyphenyl) retinamide (4-HPR, or fenretinide) has promising in vitro and in vivo antiviral activity against a range of flaviviruses and an established safety record, but there are challenges to its clinical use. This study evaluated the in vivo exposure profile of a 4-HPR dosage regime prev...
Autores principales: | Martin, Alexander J., Shackleford, David M., Charman, Susan A., Wagstaff, Kylie M., Porter, Christopher J. H., Jans, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384639/ https://www.ncbi.nlm.nih.gov/pubmed/37514160 http://dx.doi.org/10.3390/pharmaceutics15071974 |
Ejemplares similares
-
Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1
por: Poliakov, Eugenia, et al.
Publicado: (2017) -
4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells
por: Tiberio, Paola, et al.
Publicado: (2010) -
Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis
por: Asumendi, A, et al.
Publicado: (2002) -
N-(4-Hydroxyphenyl) Retinamide Potentiated Anti-Tumor Efficacy of Genistein in Human Ewing’s Sarcoma Xenografts
por: Karmakar, Surajit, et al.
Publicado: (2011) -
Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
por: Favoni, R. E., et al.
Publicado: (1998)